Lentiviral Vector Packaging for Enhanced Downstream Research

You depend on lentiviral vectors (LV) for both your research and gene therapy applications because of their long-term and stable gene expression and robust infection of both dividing and non-dividing cells. To better support your research needs, Azenta Life Sciences now offers a comprehensive array of solutions for lentiviral vectors that span from construct synthesis through viral production and even include storage of transduction-ready virus.
In this video you'll learn how Azenta Gene Synthesis enables:
• Lentiviral vectors to carry relatively large transgenes
• Low immunogenicity
• Functional titer (IFU/mL) to be determined by cell transduction and qPCR
• Ability to transduce both dividing and non-dividing cells
• Integration into the host genome and stable expression of the transgene
#Azenta #AzentaLifeSciences #lentivirus #lentiviralvectors #genomics #gene-to-lentivirus #transduction-readyvirus #transduction-readypreps #lentiviralvectors #transgenes